BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33491408)

  • 1. [Evolution of antimicrobial resistance and mortality in Staphylococcus aureus endocarditis during 15 years in a university hospital].
    Rodríguez Esteban M; Ode Febles J; Miranda Montero SI; Ramos López M; Farrais Villalba M; Álvarez Acosta L; Quijada Fumero A; Hernández Afonso J; Cabrera León A
    Rev Esp Quimioter; 2021 Apr; 34(2):100-106. PubMed ID: 33491408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis.
    Hidalgo-Tenorio C; Gálvez J; Martínez-Marcos FJ; Plata-Ciezar A; De La Torre-Lima J; López-Cortés LE; Noureddine M; Reguera JM; Vinuesa D; García MV; Ojeda G; Luque R; Lomas JM; Lepe JA; de Alarcón A
    BMC Infect Dis; 2020 Feb; 20(1):160. PubMed ID: 32085732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus.
    Casapao AM; Davis SL; McRoberts JP; Lagnf AM; Patel S; Kullar R; Levine DP; Rybak MJ
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4636-41. PubMed ID: 24890596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definite infective endocarditis: clinical and microbiological features of 155 episodes in one Japanese university hospital.
    Takayama Y; Okamoto R; Sunakawa K
    J Formos Med Assoc; 2010 Nov; 109(11):788-99. PubMed ID: 21126651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
    Cervera C; Castañeda X; de la Maria CG; del Rio A; Moreno A; Soy D; Pericas JM; Falces C; Armero Y; Almela M; Ninot S; Pare JC; Mestres CA; Gatell JM; Marco F; Miro JM;
    Clin Infect Dis; 2014 Jun; 58(12):1668-75. PubMed ID: 24647021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
    Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
    JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis.
    Pericàs JM; Messina JA; Garcia-de-la-Mària C; Park L; Sharma-Kuinkel BK; Marco F; Wray D; Kanafani ZA; Carugati M; Durante-Mangoni E; Tattevin P; Chu VH; Moreno A; Fowler VG; Miró JM;
    Clin Microbiol Infect; 2017 Aug; 23(8):544-549. PubMed ID: 28159672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditis.
    Hill EE; Peetermans WE; Vanderschueren S; Claus P; Herregods MC; Herijgers P
    Eur J Clin Microbiol Infect Dis; 2008 Jun; 27(6):445-50. PubMed ID: 18224361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A multicentric study on clinical characteristics and antibiotic sensitivity in children with methicillin-resistant
    Wu X; Yu H; He LY; Wang CQ; Xu HM; Zhao RQ; Jing CM; Chen YH; Chen J; Deng JK; Shi J; Lin AW; Li L; Deng HL; Cai HJ; Chen YP; Wen ZW; Yang JH; Zhang T; Xiao FF; Cao Q; Huang WC; Hao JH; Zhang CH; Huang YY; Ji XF
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):628-634. PubMed ID: 32842382
    [No Abstract]   [Full Text] [Related]  

  • 10. High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus.
    San-Juan R; Fernández-Ruiz M; Gasch O; Camoez M; López-Medrano F; Domínguez MÁ; Almirante B; Padilla B; Pujol M; Aguado JM;
    J Antimicrob Chemother; 2017 Jul; 72(7):2102-2109. PubMed ID: 28379553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-associated, methicillin-susceptible, and methicillin-resistant Staphylococcus aureus bone and joint infections in children: experience from India.
    Kini AR; Shetty V; Kumar AM; Shetty SM; Shetty A
    J Pediatr Orthop B; 2013 Mar; 22(2):158-66. PubMed ID: 23249998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocarditis: impact of methicillin-resistant Staphylococcus aureus in hemodialysis patients and community-acquired infection.
    Kuo CB; Lin JC; Peng MY; Wang NC; Chang FY
    J Microbiol Immunol Infect; 2007 Aug; 40(4):317-24. PubMed ID: 17712466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
    Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y
    Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis.
    Ruggero MA; Peaper DR; Topal JE
    Infect Dis (Lond); 2015 Jun; 47(6):379-84. PubMed ID: 25746601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin AUC24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization.
    Brown J; Brown K; Forrest A
    Antimicrob Agents Chemother; 2012 Feb; 56(2):634-8. PubMed ID: 22123681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hVISA and MRSA endocarditis: an 8-year experience in a tertiary care centre.
    Maor Y; Belausov N; Ben-David D; Smollan G; Keller N; Rahav G
    Clin Microbiol Infect; 2014 Oct; 20(10):O730-6. PubMed ID: 24329974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital epidemiology and antimicrobial susceptibility of isolated methicillin-resistant
    Waitayangkoon P; Thongkam A; Benjamungkalarak T; Rachayon M; Thongthaisin A; Chatsuwan T; Thammahong A; Chiewchengchol D
    Pathog Glob Health; 2020 May; 114(4):212-217. PubMed ID: 32379543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten years].
    Kızılarslanoğlu MC; Sancak B; Yağcı S; Hasçelik G; Unal S
    Mikrobiyol Bul; 2013 Apr; 47(2):199-210. PubMed ID: 23621720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia.
    Honda H; Doern CD; Michael-Dunne W; Warren DK
    BMC Infect Dis; 2011 Dec; 11():335. PubMed ID: 22142287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors and antibiotic use in methicillin-resistant Staphylococcus aureus bacteremia in hospitalized patients at Hacettepe University Adult and Oncology Hospitals (2004-2011) and antimicrobial susceptibilities of the isolates: a nested case-control study].
    Atmaca O; Zarakolu P; Karahan C; Cakır B; Unal S
    Mikrobiyol Bul; 2014 Oct; 48(4):523-37. PubMed ID: 25492648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.